{"abstract": "Documents unearthed in lawsuits over the pain drug Vioxx provide a rare, detailed look at the industry practice of ghostwriting medical research studies.", "web_url": "https://www.nytimes.com/2008/04/16/business/16vioxx.html", "snippet": "Documents unearthed in lawsuits over the pain drug Vioxx provide a rare, detailed look at the industry practice of ghostwriting medical research studies.", "lead_paragraph": "The drug maker Merck drafted dozens of research studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication, according to an article to be published Wednesday in a leading medical journal.", "print_section": "C", "print_page": "1", "source": "The New York Times", "multimedia": [], "headline": {"main": "Merck Wrote Drug Studies for Doctors", "kicker": null, "content_kicker": null, "print_headline": "Merck Wrote Drug Studies For Doctors", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Vioxx (Drug)", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Medicine and Health", "rank": 4, "major": "N"}, {"name": "subject", "value": "Research", "rank": 5, "major": "N"}, {"name": "subject", "value": "Suits and Litigation", "rank": 6, "major": "N"}], "pub_date": "2008-04-16T04:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Stephanie Saul", "person": [{"firstname": "Stephanie", "middlename": null, "lastname": "Saul", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/9189fee6-694b-5f71-bd5d-7e95bd574012", "word_count": 1002, "uri": "nyt://article/9189fee6-694b-5f71-bd5d-7e95bd574012"}